5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.67▲ | 0.67▲ | 0.66▲ | 0.67▲ | 0.76▼ |
MA10 | 0.67▲ | 0.66▲ | 0.66▲ | 0.69▼ | 0.88▼ |
MA20 | 0.66▲ | 0.66▲ | 0.67▲ | 0.81▼ | 1.02▼ |
MA50 | 0.67▲ | 0.67▼ | 0.67▼ | 0.89▼ | 1.89▼ |
MA100 | 0.67▼ | 0.69▼ | 0.79▼ | 1.05▼ | 4.56▼ |
MA200 | 0.67▼ | 0.83▼ | 0.90▼ | 1.70▼ | 13.46▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.002▲ | 0.002▲ | -0.013▼ | 0.041▲ |
RSI | 57.145▲ | 53.586▲ | 49.496▼ | 33.620▼ | 34.927▼ |
STOCH | 63.469 | 74.143 | 36.562 | 18.273▼ | 24.581 |
WILL %R | -16.722▲ | -18.206▲ | -27.570 | -83.275▼ | -92.472▼ |
CCI | 68.729 | 97.453 | 39.063 | -59.693 | -133.511▼ |
Wednesday, June 11, 2025 06:15 AM
Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment ...
|
Monday, June 02, 2025 02:24 PM
Moleculin Biotech (NASDAQ:MBRX) filed to sell 10.99M shares of common stock, warrants. This preliminary prospectus is not an offer to sell. Filing. More on Moleculin Biotech Moleculin signals first 45 ...
|
Wednesday, May 21, 2025 05:00 PM
Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 0.6441 | 0.674 | 0.6406 | 0.669 | 256,469 |
13/06/25 | 0.6537 | 0.6667 | 0.63 | 0.642 | 306,984 |
12/06/25 | 0.679 | 0.6894 | 0.655 | 0.6685 | 496,629 |
11/06/25 | 0.662 | 0.6999 | 0.662 | 0.6895 | 437,580 |
10/06/25 | 0.6624 | 0.6835 | 0.6539 | 0.6621 | 699,095 |
09/06/25 | 0.707 | 0.707 | 0.65 | 0.67 | 686,489 |
06/06/25 | 0.651 | 0.7163 | 0.627 | 0.67 | 786,611 |
05/06/25 | 0.69 | 0.7127 | 0.6443 | 0.6901 | 1,789,860 |
04/06/25 | 0.6403 | 0.80 | 0.616 | 0.6735 | 11,105,314 |
03/06/25 | 0.87 | 0.89 | 0.825 | 0.8401 | 221,931 |
|
|
||||
|
|
||||
|
|